These research findings elucidate the intricate regulatory network of the Hippo–YAP pathway in renal cancer occurrence and progression, offering valuable insights for further elucidating the molecular mechanisms underlying renal cancer and identifying novel therapeutic targets.57 This evidence concerns the gene YAP1 and renal carcinoma.